From: High expression of AGR2 in lung cancer is predictive of poor survival
AGR2 expression (integrated mean intensity) by subgroups | |||
---|---|---|---|
Group | n | (mean ± SEM) | P-value |
Gender | Â | Â | 0.025b |
 Women | 205 | 1.33 ± 0.04 |  |
 Men | 194 | 1.18 ± 0.04 |  |
Stage | Â | Â | 0.202a |
 Stage I | 224 | 1.29 ± 0.04 |  |
 Stage II | 70 | 1.16 ± 0.07 |  |
 Stage III | 77 | 1.30 ± 0.07 |  |
 Stage IV | 27 | 1.09 ± 0.09 |  |
Grade | Â | Â | 0.004a |
 Grade 1 | 63 | 1.34 ± 0.08 |  |
 Grade 2 | 112 | 1.33 ± 0.06 |  |
 Grade 3 | 158 | 1.26 ± 0.05 |  |
 Grade 4 | 35 | 0.94 ± 0.07 |  |
Histology | Â | Â | 1.07e-11a |
Adenocarcinoma | 233 | 1.43 ± 0.04 |  |
Adenosquamous carcinoma | 19 | 1.36 ± 0.14 |  |
Squamous cell carcinoma | 104 | 1.00 ± 0.05 |  |
Undifferentiated carcinoma | 33 | 0.96 ± 0.07 |  |
Smoking status | Â | Â | 3.50e-04a |
Non-smokers | 52 | 1.55 ± 0.09 |  |
Former smokers | 158 | 1.27 ± 0.04 |  |
Current smokers | 128 | 1.12 ± 0.05 |  |